Objective: The objective of the study was to evaluate a 56-yr-old male patient with an aldosteronoma for the regulation of aldosterone secretion by aberrant hormone receptors.
A berrant expression of several G-protein coupled receptors (GPCRs) frequently regulates the production of cortisol in ACTH-independent macronodular adrenal hyperplasias (AIMAH) and adrenocortical adenomas causing Cushing's syndrome or androgen excess (1, 2) . In primary aldosteronism, the mechanisms regulating aldosterone production, whereas renin and angiotensin II are suppressed, are largely unknown. In vitro studies suggest that some GPCRs are abnormally expressed in aldosteronomas. Levels of the eutopic serotonin (5-HT) 4 receptor were increased in aldosteronomas (3) . V 1 -vasopressin receptor was expressed in aldosteronomas, but at levels similar to normal adrenal (4, 5) ; administration of V 1 receptor antagonist to eight patients with primary aldosteronism did not reduce aldosterone levels (5) . Increased expression of LH/human chorionic gonadotropin receptor mRNA was found in nine of 18 aldosteronomas (6), but its effects on aldosterone secretion in vivo was not studied.
In this report, we present the results of combined in vivo and in vitro studies of the regulation of aldosterone secretion by several aberrant receptors in a case of aldosteronoma.
Clinical case
A 56-yr-old Caucasian male with a 2-yr history of high blood pressure and hypokalemia of 2.9 -3.1 mmol/liter was evaluated for primary aldosteronism. Plasma renin activity was reproducibly suppressed in sitting position at less than 0.2 ng/ml ⅐ h (normal: 0.9 to 2.5), plasma aldosterone collected without a notion of prandial status was initially 11.5-15.5 ng/dl (320 -430 pmol/ liter; normal: 10 -28 ng/dl or 277-776 pmol/liter), whereas plasma potassium was corrected. Infusion of 2 liters of 0.9% saline failed to suppress plasma aldosterone levels: time 0: 8.2 ng/dl (228 pmol/liter), time 4 h: 11.7 ng/dl (324 pmol/liter). Abdominal computed tomography scan revealed a right 2-cm adrenal adenoma (density Ͻ10 Housnfield units). Adrenal vein sampling with ACTH stimulation revealed an average aldosterone to cortisol ratio of 32 in the right compared with the left adrenal vein. A right laparoscopic adrenalectomy was performed, and 2 months later blood pressure was 135/84 mm Hg and plasma potassium was 4.1 mmol/liter without any medication. Unfortunately, the patient died shortly afterward in a car accident.
Materials and Methods

In vivo studies
The institutional ethics committee approved the investigation protocol and every participant provided an informed consent. Plasma levels of aldosterone, renin, cortisol, and ACTH were measured at 30-to 60-min intervals for 2-3 h during tests that transiently modulate the levels of ligands for potential aberrant receptors (1, 7). All tests were done fasting with the patient in supine posture for at least 60 min before the tests. A schematic view of the screening protocol is provided in Fig. 1A . On d 1 an upright posture test during 2 h was followed by a standard mixed meal and by 1-24 ACTH, 250 g iv (Cortrosyn; Organon Canada, Scarborough, Ontario, Canada). On a second day, the administration of 100 g GnRH iv (Factrel; Wyeth-Ayerst, Montréal, Québec, Canada) was followed by 200 g TRH iv (Relefact; Hoechst-Roussel, Montréal, Québec, Canada). Stimulation by 6 mg tegaserod orally (Zelnorm; Novartis Pharma Canada, Dorval, Québec, Canada) and 10 IU arginine vasopressin im (Pitressin; Parke-Davis, Scarborough, Ontario, Canada) were performed on a third day. Vasopressin test was performed during iv infusion of 4 mg dexamethasone (1 mg/h starting 3 h before vasopressin injection). Further confirmation tests included the response to 2.5 g sc of V2-vasopressin receptor agonist desmopressin (Ferring Inc., North York, Ontario, Canada), to 75 g oral glucose, and to human glucose-dependent insulinotropic peptide (GIP; Bachem Fine Chemicals, Torrance, CA) infused at a rate of 0.6 g/kg over 60 min, whereas the patient was receiving 150 ml/h of 10% glucose (8) . Before desmopressin stimulation and GIP infusion, subjects received dexamethasone 1 mg orally every 6 h for 24 h. A change of plasma aldosterone or cortisol levels of less than 25% was arbitrarily defined as no response, a 25-49% change, as a partial response, and a change of 50% or greater, as a positive response.
Assays
Plasma aldosterone and renin activity were measured by RIA kits (Diagnostic Systems Laboratories, Webster, TX) and cortisol, FSH, LH, TSH, and prolactin by immunofluorometric assay (Bayer Immuno I System, Tarrytown, NY), and ACTH by immunoradiometric assay (Allegro; Nichols Diagnostics, San Juan Capistrano, CA).
Adrenal cell dispersion studies
A portion of the aldosteronoma and the adjacent adrenal were digested with 2 mg/ml collagenase and cultured in DMEM/F12 (Invitrogen, Carlsbad, CA) supplemented with 5% fetal bovine serum (Invitrogen); 500 M of ascorbic acid (Sigma-Aldrich, St. Louis, MO); a 1% dilution of a mix of insulin, transferrin, and selenium (Invitrogen); and 6% of a mix of penicillin, streptomycin, and neomycin (Invitrogen). After 24 h of culture, culture media were replaced by media containing either ACTH (1-24), angiotensin II (Sigma) or GIP (Bachem). The media were collected 24 h later and the concentrations of cortisol and aldosterone were quantified.
Real-time RT-PCR quantification
mRNA was obtained from frozen tissues using TriZOL reagent (Invitrogen) following the manufacturer's protocol. cDNA was generated using Moloney murine leukemia virus reverse transcriptase (Invitrogen) and random hexamers (Invitrogen). We used the Quantitect SYBR green RT-PCR kit (QIAGEN, Valencia, CA) and a Rotor Gene 3000 cycler (Corbett Research, Sydney, Australia) to perform the reactions following the manufacturer's protocols. We used QuantumRNA 18S internal standards (Ambion, Austin, TX) as internal controls. Results were normalized to a commercially available pool of normal adrenal glands (CLON-TECH, Mountain View, CA). Primer sequences were as follows: GGGACAGGCCTGATCGCCCCT (forward) and TGTAGCCGCCT-GAACAAACTC (reverse) for the GIP receptor (GIPR), CAGCGT-GAAGTCCATTTCCC (forward) and GTTTTCCGATTCGGTCCA-GAC (reverse) for the V1-vasopressin receptor, CAAGGTGGAGATCGG-AGTCCT (forward) and CAGGTCTGTCAGGGCTAAGTG (reverse) for the V2-vasopressin receptor, GGGCACCCATACACGTCTTC (forward) and GGATCATGTAGGAGGAGGCATA (reverse) for the V3-vasopressin receptor, GAGCACCTTTGTTCACGTTATCT (forward) and CCAT-GAGTATCAGAAGAGCTGC (reverse) for the serotonin 5-HT4 receptor and GACTGTCCTCGTGTGGTTTTG (forward) and TAG-GCTGCCCAGCATATCAGA (reverse) for the ACTH receptor. We used the same protocol for these primer pairs: 15 min denaturation at 95 C followed by 40 cycles of 15 sec at 95 C, 30 sec at 59 C, 45 sec at 72 C, finished by a 7-min elongation at 72 C. Specificity of the reaction was assessed for each run by running a melting curve analysis of the PCR products. Efficiency of the reaction was routinely measured with dilution curve of the reverse transcription reactions. Efficiencies of at least 90% were obtained for every primer pairs and the expression ratios were determined with these efficiencies using the Pfaffl method (9).
GIPR immunohistochemistry
A commercially available polyclonal antibody to the GIPR (LS-A3840; Lifespan Biosciences, Seattle, WA) was diluted 1:80 in 2% BSA (Invitrogen) and hybridized 1 h at room temperature after a citrate treatment for 40 min in boiling water. Revelation was done using the SuperPicture horseradish peroxidase polymer conjugate broad-spectrum kit (Zymed Laboratories Inc., San Francisco, CA).
Results
In vivo studies of aberrant regulation of aldosterone secretion
The results of the in vivo tests in this patient with aldosteronoma are presented in Fig. 1 . Increases in plasma aldosterone were observed after ingestion of a mixed meal (68%) and 75 g of oral glucose (115%) (Fig. 1B) . GIP infusion increased aldosterone levels by 221% in this patient compared with 77% in a normal healthy subject (Fig. 1C) , whereas it was without effect on plasma cortisol in either subject. Aldoste-rone levels were not modified by a mixed meal in five other patients with unilateral aldosteronoma (not shown). In this patient, aldosterone also increased after administration of 6 mg of tegaserod orally (557%, Fig. 1D ) and 10 IU vasopressin im (228%, Fig. 1E ), whereas his plasma renin activity levels remained 0.2 ng/ml ⅐ h or less throughout the tests. Plasma ACTH levels remained unchanged or suppressed under dexamethasone. There were no increases of aldosterone in this patient after upright posture, GnRH, TRH (not shown), or desmopressin administration (Fig. 1E) ; ACTH 1-24 provoked a larger increase in plasma levels of aldosterone (492%) than cortisol (355%). In three normal subjects, tegaserod administration resulted in a mean increase of 265% of aldosterone (Fig. 1D) .
FIG. 1.
In vivo investigation in a patient with unilateral aldosteronoma demonstrate regulation of aldosterone production by GIP, vasopressin, and serotonin. A, Schematic representation of the investigation protocol work flow. B, Effects of a mixed meal (squares) and 75 g of glucose taken orally (triangles) on plasma aldosterone (red full lines) and cortisol (dotted line) levels. C, Infusion of GIP at 0.6 g/kg/h resulted in a larger increase in plasma aldosterone in the patient (red lines) compared with a normal healthy subject (black lines), whereas cortisol levels remained unchanged. GIP infusions were performed after suppression of ACTH by pretreatment with 1 mg of dexamethasone taken orally every 6 h for 24 h before the tests. D, The oral intake of 6 mg of tegaserod resulted in a larger increase in plasma aldosterone levels (red lines) in the patient (squares) than in three healthy subjects (triangles) but had no effect on cortisol levels (dotted lines). E, Injection of 10 IU of vasopressin im (squares), but not 2.5 g of desmopressin sc (triangles), resulted in an elevation in plasma aldosterone levels (red lines). The vasopressin and desmopressin tests were performed under suppression of ACTH by dexamethasone and had no effect on cortisol levels (dotted lines). In each figure, the arrows indicate the time of ingestion or injection.
In vitro confirmation of the aberrant responses
Incubation of dispersed aldosteronoma cells with GIP increased aldosterone production by 50% but was without effect on the normal adjacent adrenal (Fig. 2A) . ACTH increased aldosterone production in aldosteronoma (46%) and adjacent normal adrenal (53%); angiotensin II did not modify aldosterone levels in either tissue. Cortisol levels increased in response to ACTH and angiotensin II in the adjacent normal adrenal but not the adenoma; cortisol was not modified by GIP (Fig. 2B) .
Hormone receptor expression by real-time RT-PCR
Overexpression of the GIPR gene was present in this patient's aldosteronoma when compared with a pool of normal adrenal glands ( Fig. 3A ; ratio ϭ 5.98, P ϭ 0.003). This overexpression is similar to that observed in five previously reported cases of GIP-dependent AIMAH with Cushing's syndrome (ratio vs. normal adrenals ϭ 6.48, P Ͻ 0.0001) (10) . GIPR levels were not increased in the normal adrenal adjacent to the aldosteronoma, in five aldosteronomas without a response of aldosterone to mixed meal, in eight other aldosteronomas not tested in vivo with a mixed meal, or in the adrenals of five patients with persistent Cushing's disease. Overexpression of the ACTH receptor (ratio compared with normal adrenal pool ϭ 5.12, P ϭ 0.002) and the 5-HT4 serotonin receptor (ratio ϭ 22.8, P ϭ 0.0001) were also found in this patient's aldosteronoma (Fig. 3, B and C) . For the three subtypes of vasopressin receptors, overexpression of the V2 subtype was found in this aldosteronoma (ratio of 16.7, although raw levels were much lower than those of the V1 receptor), whereas the V1 and V3 receptors were similar to control normal adrenal pool and adjacent normal adrenal (Fig. 3, D-F) .
Presence of the GIPR protein in the aldosteronoma
Histology of the aldosteronoma revealed two cell populations: one of zona fasciculata type cells, with prominent cytoplasm, and the other composed of zona glomerulosa-like cells with a granular aspect (Fig. 4A) . Immunostaining identified the presence of the GIPR protein in clusters of small cells throughout the patient's aldosteronoma (Fig. 4B) , whereas it was absent in another aldosteronoma with low levels of GIPR expression by RT-PCR (Fig. 4C) . In the normal adrenal adjacent to the aldosteronoma (Fig. 4D ) and in two normal control adrenal glands (not shown), GIPR staining was present mainly in the zona glomerulosa, to a lesser extent in zona reticularis, and in endothelial cells of blood vessels; the capsule, zona fasciculata, and medulla were all negative.
Discussion
Primary aldosteronism is responsible for up to 10% of hypertension (11, 12) . With the exception of rare genetic forms of glucocorticoid-remediable aldosteronism (familial aldosteronism type 1) or congenital adrenal hyperplasia due to CYP11B1 or CYP17 deficiencies, the mechanisms controlling aldosterone secretion when renin levels are suppressed in aldosteronomas or idiopathic bilateral aldosteronism are largely unknown (11, 12) . Based on the role of aberrant hormone receptors in regulating steroidogenesis in adrenal tumors or AIMAH-secreting cortisol or androgen (1, 2, 4, 7, 8) , we adapted the in vivo screening protocol to evaluate the presence of aberrant regulation of aldosterone secretion in this index case with a unilateral aldosteronoma. The stimulation of aldosterone secretion by a mixed meal but also by oral glucose, a preferential stimulator of GIP release by intestinal K cells, suggested the presence of aberrant GIPRs in this aldosteronoma. This was supported by the response of aldosterone, but not cortisol, during GIP infusion in this patient. The overexpression and functionality of GIPR in this aldosteronoma was confirmed in vitro by cell dispersal, real-time RT-PCR, and immunohistochemistry studies.
Specific staining for the GIPR by immunohistochemistry was also found in the zona glomerulosa cells of the adrenal cortex adjacent to the aldosteronoma and in other normal adrenal glands. The small increase of aldosterone during GIP infusion in only one normal control suggests that GIPR is functional in nor- mal zona glomerulosa, but this requires confirmation by further studies with a larger number of normal subjects. The presence of GIPR in adrenocortical zona glomerulosa and vascular endothelial cells may explain the low amounts of GIPR previously found by RT-PCR in normal adrenal glands (1, 10, 13) . As GIPR is expressed normally in zona glomerulosa in humans, but not zona fasciculata, its overexpression in aldosteronomas constitutes an increased expression of a eutopic receptor (as for 5-HT 4 receptor), whereas it is expressed ectopically in zona fasciculata cells in cortisol-secreting tumors. We also found that the overexpression of GIPR is not present in the majority of aldosteronomas and probably results from a rare somatic event, as found previously for GIP-dependent cortisol secreting adenomas or macronodular hyperplasia (14) . It would have been interesting to investigate the normalization of the GIP responsiveness postoperatively in this patient, but his premature accidental death prevented this study.
Other aberrant responses were also found in the same patient. The overexpression of the 5-HT4 receptor in this aldosteronoma confirms previous studies in patients with aldosteronomas (3). We also found a larger increase of aldosterone in this patient compared with three control subjects induced by tegaserod, a specific 5-HT4 agonist, as reported previously with cisapride or the less specific agonist metoclopramide (15) . This aldosteronoma was also found to increase its secretion of aldosterone in vivo after vasopressin administration. As reported previously, V1-vasopressin receptor levels were not overexpressed by RT-PCR in this aldosteronomas compared with normal adrenals (4, 5) . Despite relatively increased levels of V2-vasopressin receptor in the aldosteronoma compared with normal adrenals, the lack of effect of desmopressin on aldosterone secretion indicates that the V2R did not mediate the effect of vasopressin on aldosterone secretion. The aldosterone response to vasopressin despite normal levels of eutopic V1R could result from an increased coupling mechanism to the steroidogenic effector system (5). Serotonin and vasopressin have also been demonstrated to be secreted by mast cells or chromaffin cells in normal adrenals and adrenocortical adenomas and hyperplasias, suggesting paracrine regulation of aldosterone secretion (5, 16, 17) . In accordance with previous study (18) , we also found increased ACTH receptor (melanotonin-2 receptor) levels in the aldosteronoma, and ACTH 1-24 evoked a larger increase of aldosterone than cortisol in this patient. It will thus be important when investigating patients with primary aldosteronism for the presence of aberrant receptors to suppress endogenous ACTH levels with dexamethasone.
The identification of aberrant hormone receptors in aldosterone-secreting tumors should modify significantly its investigation. Variable blood levels of ligands for the aberrant receptors could modify greatly the plasma aldosterone/renin ratios. In contrast to GIP-dependent Cushing's syndrome (7, 8) , GIPR overexpression in this aldosteronoma did not result in ACTH suppression; fasting aldosterone levels were not suppressed but fluctuated probably after levels of ACTH, GIP, serotonin, or vasopressin.
As demonstrated for cortisol-secreting macronodular hyperplasias or adenomas (1, 7, 19, 20) , specific pharmacological blockade of the aberrant receptors could offer new therapeutic approaches in the treatment of primary aldosteronism, particularly secondary to bilateral nodular hyperplasia. Further systematic studies of large series of patients with primary aldosteronism should be conducted to identify the role and diversity of aberrant hormone receptors in this frequent pathology.
